课题基金 / 基金详情

Planning IUCRC at NJIT Center for Integrated Material Science and Engineering for Pharmaceutical Products (CIMSEPP)

Planning IUCRC at NJIT Center for Integrated Material Science and Engineering for Pharmaceutical Products (CIMSEPP)
在 NJIT 医药产品综合材料科学与工程中心 (CIMSEPP) 规划 IUCRC
批准号:
1841433
负责人:
Rajesh Dave
金额:
$1.5万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-12-01 至 2019-11-30

项目摘要

项目成果

Rajesh Dave的其他基金

相似基金

相关文献

中文摘要
翻译
该IUCRC规划项目的重点是建立一个合作的三所大学中心,以推进基础材料科学和工程研究,促进高质量的药品开发。 美国的制药业是一个重要的,万亿美元的产业,对人口的健康和福祉产生广泛的影响。 然而,存在一些主要问题,例如,市场增长放缓、新药上市时间长、成本高、产品质量和监管问题以及药品短缺。这些问题的出现主要是由于药品的高度复杂性,其中包含许多不同的成分,对制造工艺的理解不足,以及缺乏从材料特性评估产品性能的预测工具。该中心旨在通过范式转变机制方法来解决这些问题和行业需求,以发展对工艺和材料性能对产品性能影响的预测性理解。预计基于材料科学的转化研究将产生重大的经济影响,因为它可以提高产品质量,减少产品故障,简化制造操作,并显着减少产品开发时间和制造成本。该中心还将通过前沿研究方法、技术转让、创新和创业培训,对少数群体的学生产生积极影响。拟议的研究旨在发展对颗粒药物产品及其工艺工程的结构-功能-性能的基本理解,为应用晶体和颗粒工程提高药物生物利用度、可制造性、产品稳定性和产品质量。旨在产生变革性影响的中心研究重点是:A)颗粒和晶体工程,B)材料和产品性能的模型预测理解,以及C)生物利用度增强和稳定性。Tre CIMSEPP团队将在分子/颗粒水平上深入了解受生产工艺影响的材料特性以及药物和添加剂之间的相互作用。NJIT在颗粒接触物理学方面的专业知识将使颗粒团聚,药物含量均匀性和片剂重量变化的预测模型的开发使用无量纲参数(S)的基础上,材料节省测量颗粒特性,如大小,形状和粗糙度。颗粒过程建模的专业知识,例如,混合、涂覆和干燥,采用离散单元法、群体平衡建模和多相CFD,将使人们更好地理解传统和新兴技术,如薄膜和3D打印。中心范围内的合作将带来改善药物溶解度、溶出速率和生物利用度、个性化药物和儿科给药的技术,同时减少产品设计、工艺开发、扩大规模以及实现连续生产的时间。该奖项反映了NSF的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
英文摘要
This IUCRC planning project focuses on establishing a collaborative three-university center to advance fundamental materials science and engineering research for facilitating high quality drug product development. The pharmaceutical sector in the USA is a major, trillion-dollar industry, having broad impacts on the health and well-being of its population. Yet, there are major problems, e.g., slowing market growth, long time and high costs of bringing a new drug to market, product quality and regulatory issues, and drug shortages. These arise largely due to highly complex nature of pharmaceutical products, which contain many different components, the inadequate understanding of the manufacturing processes, and lack of predictive tools to assess product performance from material properties. This Center aims to address these problems and the needs of industry through paradigm shifting mechanistic approach for developing predictive understanding of the impact of processes and material properties on product performance. Proposed material science based translational research is expected to have significant economic impact, due to improved product quality, reduced product failures, simplified manufacturing operations, and significantly reducing product development times and manufacturing costs. The Center will also positively impact students from under-represented minority groups, through training in cutting edge research methodologies, tech-transfer, innovation and entrepreneurship.The proposed research aims at developing a fundamental understanding of structure-function-performance of particulate-based drug products and their process engineering, paving the way for applying crystal and particle engineering towards enhancing drug bioavailability, manufacturability, product stability, and product quality. Center research thrusts, designed for transformative impact, are: A) Particle and Crystal Engineering, B) Model Predictive Understanding of Materials and Product Performance, and C) Bioavailability Enhancement and Stability. Tre CIMSEPP team will advance understanding of the material properties and interactions among drug(s) and additives at the molecular/particulate level as affected by manufacturing processes. NJIT's expertise in particle contact-physics will enable development of predictive models for particle agglomeration, drug content uniformity, and tablet weight variation using dimensionless parameter(s) based on material sparing measurements of particle properties such as size, shape, and roughness. Expertise in modeling of particle processes, e.g., mixing, coating, and drying, employing discrete element method, population balance modeling, and multi-phase CFD, will enable better understanding of traditional and emerging technologies, such as thin films and 3D printing. Center-wide collaborations will lead to technologies for improved drug solubility, dissolution rate and bioavailability, personalized medicines and pediatric dosing, while reducing time for product design, process development, scale-up, as well as enabling continuous manufacturing.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IUCRC Phase I NJIT: Center for Integrated Material Science and Engineering of Pharmaceutical Products (CIMSEPP)
  • 批准号:
    2137209
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $91.0万
  • 财政年份:
    2022
  • 负责人:
    Rajesh Dave
  • 依托单位:
PFI-RP: Commercializing innovations in design and manufacture of fine pharmaceutical powders for cheaper and better medicines
  • 批准号:
    1919037
  • 项目类别:
    Standard Grant
  • 资助金额:
    $55.0万
  • 财政年份:
    2019
  • 负责人:
    Rajesh Dave
  • 依托单位:
RET Site for Structured Organic Particulates
  • 批准号:
    1301071
  • 项目类别:
    Standard Grant
  • 资助金额:
    $50.0万
  • 财政年份:
    2014
  • 负责人:
    Rajesh Dave
  • 依托单位:
AIR Option 1: Technology Translation - Proof-of-concept testing and technology translation for engineered nanocomposites
  • 批准号:
    1312125
  • 项目类别:
    Standard Grant
  • 资助金额:
    $15.0万
  • 财政年份:
    2013
  • 负责人:
    Rajesh Dave
  • 依托单位:
海外基金